Literature DB >> 30023399

Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations.

Lihui Yin1, Zijun Y Xu-Monette2, Jay Brock1, Yong Li3, Ken H Young2,4.   

Abstract

Entities:  

Year:  2018        PMID： 30023399      PMCID： PMC6036001          DOI： 10.21037/atm.2018.05.36

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  20 in total

Review 1.  Immunosenescence: emerging challenges for an ageing population.

Authors:  Danielle Aw; Alberto B Silva; Donald B Palmer
Journal:  Immunology       Date:  2007-02-15       Impact factor: 7.397

2.  Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population.

Authors:  Annegret Hofscheier; Ana Ponciano; Irina Bonzheim; Patrick Adam; Carmen Lome-Maldonado; Teresa Vela; Evelyn Cortes; Carlos Ortiz-Hidalgo; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Mod Pathol       Date:  2011-04-15       Impact factor: 7.842

3.  Epstein-barr virus-positive diffuse large B-cell lymphoma during therapy with alemtuzumab for T-cell prolymphocytic leukemia.

Authors:  Aliyah R Sohani; Judith A Ferry; Priscilla S Chang; Jeremy S Abramson
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

4.  Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma.

Authors:  J-H Liang; T-X Lu; T Tian; L Wang; L Fan; J Xu; R Zhang; Q-X Gong; Z-H Zhang; J-Y Li; W Xu
Journal:  Clin Microbiol Infect       Date:  2015-03-02       Impact factor: 8.067

Review 5.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

6.  Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy.

Authors:  Z Yao; L Deng; Z Y Xu-Monette; G C Manyam; P Jain; A Tzankov; C Visco; G Bhagat; J Wang; K Dybkaer; W Tam; E D Hsi; J H van Krieken; M Ponzoni; A J M Ferreri; M B Møller; J N Winter; M A Piris; L Fayad; Y Liu; Y Song; R Z Orlowski; H Kantarjian; L J Medeiros; Y Li; J Cortes; K H Young
Journal:  Leukemia       Date:  2017-07-12       Impact factor: 11.528

7.  CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.

Authors:  Shimin Hu; Zijun Y Xu-Monette; Aarthi Balasubramanyam; Ganiraju C Manyam; Carlo Visco; Alexander Tzankov; Wei-min Liu; Roberto N Miranda; Li Zhang; Santiago Montes-Moreno; Karen Dybkær; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Qin Huang; Jooryung Huh; Weiyun Ai; Maurilio Ponzoni; Andrés J M Ferreri; Xiaoying Zhao; Jane N Winter; Mingzhi Zhang; Ling Li; Michael B Møller; Miguel A Piris; Yong Li; Ronald S Go; Lin Wu; L Jeffrey Medeiros; Ken H Young
Journal:  Blood       Date:  2013-01-23       Impact factor: 22.113

Review 8.  EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.

Authors:  Jorge J Castillo; Brady E Beltran; Roberto N Miranda; Ken H Young; Julio C Chavez; Eduardo M Sotomayor
Journal:  Am J Hematol       Date:  2016-05       Impact factor: 10.047

9.  Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations.

Authors:  Sylvia Hoeller; Alexandar Tzankov; Stefano A Pileri; Philip Went; Stephan Dirnhofer
Journal:  Hum Pathol       Date:  2009-11-13       Impact factor: 3.466

10.  Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.

Authors:  Ting-Xun Lu; Jin-Hua Liang; Yi Miao; Lei Fan; Li Wang; Xiao-Yan Qu; Lei Cao; Qi-Xing Gong; Zhen Wang; Zhi-Hong Zhang; Wei Xu; Jian-Yong Li
Journal:  Sci Rep       Date:  2015-07-23       Impact factor: 4.379
View more
  1 in total

1.  Efficacy and safety of CD19 chimeric antigen receptor T cells in the treatment of 11 patients with relapsed/refractory B-cell lymphoma: a single-center study.

Authors:  Chen Huang; Lili Wu; Ruixia Liu; Weijing Li; Zheng Li; Jianqiang Li; Lihong Liu; Baoen Shan
Journal:  Ann Transl Med       Date:  2020-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.